IDEA4RC FHIR Implementation Guide
0.1.0 - CI Build 150

IDEA4RC FHIR Implementation Guide, published by IDEA4RC Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/idea4rc/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 IDEA4RC FHIR IG - Home Page
... 2 IDEA4RC Model Overview
... 3 IDEA4RC Detailed ERD Model
... 4 IDEA4RC Logical Models
... 5 Useful Downloads
... 6 Condition-secondaryCancer-eu-i4rc Relationships
... 7 Encounter-eu-i4rc Relationships
... 8 Condition-primaryCancer-eu-i4rc Relationships
... 9 sarcoma-cancer-stage-group Relationships
... 10 hn-cancer-stage-group Relationships
... 11 episodeOfCare-eu-i4rc Relationships
... 12 MedicationAdministration-eu-i4rc Relationships
... 13 Subject Relationships
... 14 PatientFollowUp Relationships
... 15 EpisodeEvent Relationships
... 16 HospitalPatientRecords Relationships
... 17 CancerEpisode Relationships
... 18 AdverseEvent Relationships
... 19 GeneticTestExpression Relationships
... 20 Surgery Relationships
... 21 Radiotherapy Relationships
... 22 Artifacts Summary
.... 22.1 Adverse Event
.... 22.2 Cancer Episode
.... 22.3 Episode Event
.... 22.4 Genetic Test Expression
.... 22.5 Hospital Patient Records
.... 22.6 Patient
.... 22.7 Patient Follow-Up
.... 22.8 Radiotherapy
.... 22.9 Surgery
.... 22.10 Systemic Treatment
.... 22.11 Cancer Episode Model to this guide Map
.... 22.12 Episode Event Model to this guide Map
.... 22.13 Genetic Test Expression Model to this guide Map
.... 22.14 Genetic Test to this guide Map
.... 22.15 Hospital Patient Records Model to this guide Map
.... 22.16 Patient (Subject) Model to this guide Map
.... 22.17 Patient Follow up Model to this guide Map
.... 22.18 Radiotherapy Model to this guide Map
.... 22.19 Surgery Model to this guide Map
.... 22.20 Observation: Alcohol use
.... 22.21 Observation: Cancer Treatment
.... 22.22 Observation: Charlson Comorbidity Index
.... 22.23 Observation: Comorbidities
.... 22.24 Observation: ECOG Performance Status
.... 22.25 Observation: Karnofsky Performance Status
.... 22.26 Observation: Occurrence of the other cancer
.... 22.27 Observation: Tobacco use
.... 22.28 Patient: IDEA4RC
.... 22.29 Condition: Metastatic Cancer
.... 22.30 Condition: Primary Cancer
.... 22.31 Observation: Diagnosis details
.... 22.32 Observation: Head Neck Cancer Stage Group
.... 22.33 Observation: Localized Category (Stage, Sarcoma)
.... 22.34 Observation: LocoRegional Category (Stage, Sarcoma)
.... 22.35 Observation: Radiological Extra-nodal extension (rENE)
.... 22.36 Observation: Sarcoma Cancer Stage Group
.... 22.37 Observation: TNM Distant Metastases Category
.... 22.38 Observation: TNM Primary Tumor Category
.... 22.39 Observation: TNM Regional Nodes Category
.... 22.40 Encounter: IDEA4RC
.... 22.41 Observation: date of the last contact
.... 22.42 Observation: Status at the Last Follow Up
.... 22.43 Procedure: Surgery
.... 22.44 Procedure: Radiotherapy
.... 22.45 MedicationAdministration: Chemotherapy
.... 22.46 EpisodeOfCare: IDEA4RC
.... 22.47 Clinical Stage
.... 22.48 Diagnosis
.... 22.49 Disease Extent
.... 22.50 Drugs for Treatments
.... 22.51 Isolated Limb Perfusion
.... 22.52 Overall Treatment Response
.... 22.53 Pathological Stage
.... 22.54 Regional Deep Hyperthemia
.... 22.55 AdverseEvent: IDEA4RC
.... 22.56 Bundle: IDEA4RC
.... 22.57 Observation: test results
.... 22.58 Observation: Yes / No assertions
.... 22.59 Procedure: Other Treatment
.... 22.60 Body Location Qualifier
.... 22.61 Condition related to resource
.... 22.62 Laterality Qualifier
.... 22.63 Performed Timing
.... 22.64 Previous Status
.... 22.65 Race Extension
.... 22.66 Radiotherapy Dose Delivered To Volume Extension
.... 22.67 Radiotherapy Energy or Isotope
.... 22.68 Radiotherapy Modality And Technique Extension
.... 22.69 Radiotherapy Modality Extension
.... 22.70 Radiotherapy Number of Sessions Extension
.... 22.71 Radiotherapy Technique Extension
.... 22.72 Relapse Type
.... 22.73 Same custodian flag
.... 22.74 Affected Organs (surgery)
.... 22.75 Alcohol Usage Status: Athena
.... 22.76 Alcohol Usage Status: SNOMED CT
.... 22.77 Antineoplastic and immunostimulating agents
.... 22.78 Beam Quality
.... 22.79 Body site qualifier
.... 22.80 Calculated|Estimated
.... 22.81 Cancer Chondro Osseous Tumours: Athena
.... 22.82 Cancer diagnosis: Athena
.... 22.83 Cancer Endometrial stromal and related Tumors: Athena
.... 22.84 Cancer Event Type: Athena
.... 22.85 Cancer Histology Adenocarcinoma: Athena
.... 22.86 Cancer Histology Neuroendocrine: Athena
.... 22.87 Cancer Histology Odontogenic Carcinoma: Athena
.... 22.88 Cancer Histology SNUC: Athena
.... 22.89 Cancer Histology Squamous: Athena
.... 22.90 Cancer Histology Subgroup Adipocytic Tumours: Athena
.... 22.91 Cancer Histology Subgroup Fmt Tumours: Athena
.... 22.92 Cancer Histology Subgroup So called Fibrohistiocytic Tumours: Athena
.... 22.93 Cancer Miscellanious mesenchimal tumors: Athena
.... 22.94 Cancer Mixed epithelial and mesenchymal tumours: Athena
.... 22.95 Cancer Pericytic Perivascular Tumours: Athena
.... 22.96 Cancer Peripheral Nerve Sheath Tumors: Athena
.... 22.97 Cancer Skeletal Muscle Tumours: Athena
.... 22.98 Cancer Smooth Muscle Tumours: Athena
.... 22.99 Cancer Stage Grading: Athena
.... 22.100 Cancer Stage Group Value: Athena
.... 22.101 Cancer Stage Group: Athena
.... 22.102 Cancer Tumors Of Uncertain Differentiation: Athena
.... 22.103 Cancer undif. small round cell sarcomas of bone and soft tissue: Athena
.... 22.104 Cancer Vascular Tumours: Athena
.... 22.105 Chemotherapy cumulative dose units
.... 22.106 Comorbidities: Athena
.... 22.107 Comorbidities: SNOMED
.... 22.108 Country: athena
.... 22.109 Current Smoking Status: Athena
.... 22.110 ECOG Performance Status
.... 22.111 Event Type
.... 22.112 Extranodal Extension
.... 22.113 Gender: Athena
.... 22.114 Genetic Tests performed (Yes/no/Unk)
.... 22.115 Genito urinary subsite: Athena
.... 22.116 Hypopharynx subsite: Athena
.... 22.117 Hypopharynx subsite: Snomed CT
.... 22.118 Intra abdominal subsite: Athena
.... 22.119 Intra thoracic subsite : Athena
.... 22.120 Larynx subsite: Athena
.... 22.121 Larynx subsite: Snomed CT
.... 22.122 Lip subsite: Athena
.... 22.123 Lip subsite: Snomed CT
.... 22.124 Margins After Surgery
.... 22.125 Metastatis: Athena
.... 22.126 Nasal cavity and paranasal sinuses subsite: Athena
.... 22.127 Nasal cavity and paranasal sinuses subsite: Snomed CT
.... 22.128 Nasopharynx subsite: Athena
.... 22.129 Nasopharynx subsite: Snomed CT
.... 22.130 Not Performed|Unknown
.... 22.131 Observation Codes for Distant Metastases Category
.... 22.132 Observation Codes for Primary Tumor Category
.... 22.133 Observation Codes for Regional Node Category
.... 22.134 Occurrence of other cancer
.... 22.135 Oral cavity subsite: Athena
.... 22.136 Oral cavity subsite: Snomed CT
.... 22.137 Oropharynx subsite: Athena
.... 22.138 Oropharynx subsite: Snomed CT
.... 22.139 Pathological M
.... 22.140 Pathological N
.... 22.141 Pathological T
.... 22.142 Positive-Negative-No Test: Athena
.... 22.143 Race
.... 22.144 Radiotherapy Device Type
.... 22.145 Reason For End Of Treatment
.... 22.146 Sarcoma Staging: localized disease
.... 22.147 Sarcoma Staging: loco-regional category
.... 22.148 Setting Radiotherapy
.... 22.149 Simple measures
.... 22.150 Site of metastasis
.... 22.151 Site rare (IDEA4RC)
.... 22.152 Smoking Status: LOINC
.... 22.153 Status at the Last Follow Up
.... 22.154 Subsites: Athena
.... 22.155 Subsites: SNOMED CT
.... 22.156 Surgery Complication
.... 22.157 Surgery Intention
.... 22.158 Surgery Outcome
.... 22.159 Surgical Complications
.... 22.160 Surgical Procedure Category
.... 22.161 Surgical Procedure Type
.... 22.162 TNM Distant Metastases Category Value Set
.... 22.163 TNM Primary Tumor Category Value Set
.... 22.164 TNM Regional Nodes Category Value Set
.... 22.165 Tobacco Product
.... 22.166 Treatment completed as planned
.... 22.167 Treatment Response
.... 22.168 Treatment Setting
.... 22.169 Treatment Technique
.... 22.170 Trunk wall subsite: Athena
.... 22.171 Type of Biopsy
.... 22.172 Type of Diagnosis
.... 22.173 Type of surgical approach
.... 22.174 Type of Systemic Treatment
.... 22.175 Type of Treatment
.... 22.176 Types of Yes/No observations
.... 22.177 Upper and Lower limbs subsite: Athena
.... 22.178 Yes-No-Unk: Athena
.... 22.179 IDEA4RC Code System
.... 22.180 HN Stage Model to this guide Map
.... 22.181 Other Treatment to this guide Map
.... 22.182 Radiotherapy Model to this guide Map
.... 22.183 Stage Model to this guide Map
.... 22.184 Actor: Head and Neck
.... 22.185 Actor: Sarcoma
.... 22.186 Condition: Grade 2 tumor with several body sites and evidences
.... 22.187 Condition: Metastasis bone and pleura
.... 22.188 Condition: NOT CLEAR WHAT IT REPRESENTS..TO BE DISCUSSED
.... 22.189 Condition: Stable Disease
.... 22.190 encounter-id-14
.... 22.191 EpisodeOfCare
.... 22.192 GOFSH-GENERATED-id-28
.... 22.193 GOFSH-GENERATED-id-30
.... 22.194 GOFSH-GENERATED-id-36
.... 22.195 Observation: Alcohol use
.... 22.196 Observation: BMI
.... 22.197 Observation: C reactive protein Positive
.... 22.198 Observation: Charlson Comorbidity Index
.... 22.199 Observation: comorbidity
.... 22.200 Observation: date of the last contact
.... 22.201 Observation: Diagnosis
.... 22.202 Observation: Dimension of Tumor
.... 22.203 Observation: Distant metastases clinical M1
.... 22.204 Observation: Distant metastases pathology M1
.... 22.205 Observation: ECOG Performance Status score
.... 22.206 Observation: Epstein Barr virus DNA Negative
.... 22.207 Observation: gene Mutation Analysis Performed yes
.... 22.208 Observation: Human papilloma virus Negative
.... 22.209 Observation: immunohiostochemestry analysis performed
.... 22.210 Observation: Karnofsky Performance Status score
.... 22.211 Observation: Number of mitoses per HPF
.... 22.212 Observation: Occurrence of other Cancer: Hamartoma
.... 22.213 Observation: Primary tumor clinical T0
.... 22.214 Observation: Primary tumor pathological T0
.... 22.215 Observation: Radiological Extra-nodal extension
.... 22.216 Observation: Regional lymph nodes Clinical N1
.... 22.217 Observation: Regional lymph nodes pathology N3b
.... 22.218 Observation: Surgery treatment occurred
.... 22.219 Observation: TNM clinical stage grouping
.... 22.220 Observation: TNM pathology stage grouping
.... 22.221 Observation: Tobacco use panel
.... 22.222 Patient: race extension
.... 22.223 Procedure: Isolated limb perfusion